![Anne Johnson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anne Johnson
Director Financiero/CFO en ATAI LIFE SCIENCES N.V. .
Fortuna: 115 536 $ al 31/05/2024
Perfil
Ms. Anne Johnson, CPA, is a Chief Financial & Accounting Officer at ATAI Life Sciences NV.
Ms. Johnson was previously employed as a Controller by Aruvant Sciences, Inc., a Corporate Controller by Chimerix, Inc., and a Vice President-Finance by Xanodyne Pharmaceuticals, Inc. She received her undergraduate degree from The University of North Carolina at Wilmington.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
ATAI LIFE SCIENCES N.V.
0.04% | 09/04/2024 | 73 590 ( 0.04% ) | 115 536 $ | 31/05/2024 |
Cargos activos de Anne Johnson
Empresas | Cargo | Inicio |
---|---|---|
ATAI LIFE SCIENCES N.V. | Director Financiero/CFO | 13/10/2023 |
Antiguos cargos conocidos de Anne Johnson.
Empresas | Cargo | Fin |
---|---|---|
CHIMERIX, INC. | Comptroller/Controller/Auditor | - |
Xanodyne Pharmaceuticals, Inc.
![]() Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Director Financiero/CFO | - |
Aruvant Sciences, Inc.
![]() Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Comptroller/Controller/Auditor | - |
Formación de Anne Johnson.
The University of North Carolina at Wilmington | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ATAI LIFE SCIENCES N.V. | Health Technology |
CHIMERIX, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Aruvant Sciences, Inc.
![]() Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Health Technology |
Xanodyne Pharmaceuticals, Inc.
![]() Xanodyne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xanodyne Pharmaceuticals, Inc. operates as an integrated specialty pharmaceutical company with both development and commercial capabilities focused on pain management and women's healthcare. It markets a portfolio of prescription pharmaceuticals and a line of prenatal vitamins. The firm's product candidates include XP12B, a tranexamic acid modified release oral tablet for the reduction of menstrual blood loss in women, who suffer from menorrhagia or excessive menstrual bleeding; and XP20B is a combination propoxyphene and acetaminophen modified release oral tablet for the treatment of mild to moderate pain. The company was founded by Gilbert R. Gonzales and Roger Dale Griggs in May 2001 and is headquartered in Newport, KY. | Health Technology |
- Bolsa de valores
- Insiders
- Anne Johnson